Breadcrumb

null Bertrand Lebouché wins the CAHR-CANFAR Excellence in Research Award

Deeply committed to outreach, Dr. Lebouché is being recognized for conducting patient-oriented clinical research with people with HIV

SOURCE: RI-MUHC

Bertrand Lebouché, MD, PhD, is a scientist in the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the McGill University Health Centre and conducts research at the Centre for Outcomes Research and Evaluation
Bertrand Lebouché, MD, PhD, is a scientist in the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the McGill University Health Centre and conducts research at the Centre for Outcomes Research and Evaluation

Dr. Bertrand Lebouché, a scientist in the Infectious Diseases and Immunity in Global Health Program at the Research Institute of the McGill University Health Centre (RI-MUHC), has won the 2023 Canadian Association for HIV Research – Canadian Foundation for AIDS Research (CAHR-CANFAR) Excellence in HIV Research Award, Clinical Sciences track. An associate professor and director of the Clinician Scholarship program in the Department of Family Medicine, Faculty of Medicine and Health Sciences, McGill University, Dr. Lebouché is a clinician scientist with an appointment in the Department of Family Medicine at the MUHC. He holds a CIHR SPOR Mentorship Chair in Innovative Clinical Trials in HIV and conducts research in the Centre for Outcomes Research and Evaluation at the RI-MUHC.

The CAHR-CANFAR Excellence in Research Awards celebrate the contributions of Canadian HIV/AIDS researchers in Canada and internationally. They are awarded annually to a mid-career researcher who has achieved a track record of excellence and demonstrated commitment to improving the lives of those living with or at risk for HIV. Dr. Lebouché is being recognized for conducting patient-oriented clinical research with people with HIV to develop a new, connected patient-reported measure, to pioneer the use of the Opal patient portal in HIV care, and to create a new AI-based chatbot to improve the HIV care pathway. His commitment to outreach is evidenced by his nomination in August 2022 as Grand Marshal for Pride Montreal for his LGBTQ2+ engagement. He will receive the CAHR-CANFAR award during the CAHR conference in Quebec City this month.

“Canada’s HIV research community is very diverse with clinicians, basic scientists, and community groups,” says Dr. Lebouché. “Being honoured with the CAHR-CANFAR research award by people I feel are peers, or ‘ahead of me’ in many ways, is extremely touching. It is a recognition for my research team and myself for what we are doing to improve the daily lives of people with HIV and better engage them with innovative tools.”

Learn more about this award on the CAHR-CANFAR website.

Published April 26, 2023; updated May 5, 2023